// App-Quantinova.ai

T1187 2016 AHA : Cycloxygenase 2 Preserves Immunoprivilege of Allogeneic Mesenchymal Stem Cells in the Ischemic Heart

Researchers

Presenter

  • Ejlal Abu-El Rub

Principal Investigators

  • Glen Lester Sequiera

  • Sekaran Saravanan

  • Meenal Moudgil

  • Sanjiv Dhingra

Medical Centers

  • St. Boniface Hosp Res Ctr, Inst of Cardiovascular Sciences, Winnipeg, MB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Myocardial injury

Biomarkers

  • Prostaglandin E2

  • Cyclooxygenase-2

  • Mesenchymal stem cells

Drug/Treatment

  • Dinoprostone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved